0001104659-24-025580.txt : 20240220 0001104659-24-025580.hdr.sgml : 20240220 20240220164425 ACCESSION NUMBER: 0001104659-24-025580 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20240215 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240220 DATE AS OF CHANGE: 20240220 FILER: COMPANY DATA: COMPANY CONFORMED NAME: COGNITION THERAPEUTICS INC CENTRAL INDEX KEY: 0001455365 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40886 FILM NUMBER: 24654292 BUSINESS ADDRESS: STREET 1: 2403 SIDNEY STREET STREET 2: SUITE 261 CITY: PITTSBURGH STATE: PA ZIP: 15203 BUSINESS PHONE: 412-481-2210 MAIL ADDRESS: STREET 1: 2500 WESTCHESTER AVE CITY: PURCHASE STATE: NY ZIP: 10577 FORMER COMPANY: FORMER CONFORMED NAME: COGNITION THERAPUTICS INC DATE OF NAME CHANGE: 20090204 8-K 1 tm246515d1_8k.htm FORM 8-K

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 15, 2024

Cognition Therapeutics, Inc.

(Exact name of registrant as specified in its charter)

Delaware		001-40886		13-4365359
(State or other jurisdiction of incorporation or organization)		(Primary Standard Industrial Classification Code Number)		(I.R.S. Employer Identification No.)

2500 Westchester Ave. Purchase, NY		10577
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (412) 481-2210

Not Applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class		Trading Symbol		Name of Exchange on Which Registered
Common Stock, par value $0.001 per share		CGTX		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company x

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On February 15, 2024, the Board of Directors of Cognition Therapeutics, Inc. (the “Company”), based upon the recommendation of the Compensation Committee, granted certain Performance Restricted Stock Units (“PSUs”) to employees and officers of the Company, including (i) Lisa Ricciardi, the Company’s Chief Executive Officer, (ii) John Doyle, the Company’s Chief Financial Officer, and (iii) Anthony Caggiano, the Company’s Chief Medical Officer. Ms. Ricciardi was awarded 150,000 PSUs, Mr. Doyle was awarded 60,000 PSUs and Dr. Caggiano was awarded 130,000 PSUs. The PSUs will vest in two equal installments, in each case, upon the one year anniversary of the achievement of certain clinical milestones.

The foregoing description of the PSUs does not purport to be complete and is subject to, and qualified in its entirety by, the form of Performance Restricted Stock Unit Award Agreement, which is filed and attached hereto as Exhibit 10.1, and is incorporated herein by reference.

Item 9.01

Financial Statements and Exhibits

The following exhibits are being filed herewith:

(d) Exhibits

Exhibit No.		Document

10.1		Form of Performance Restricted Stock Unit Award Agreement.
104		Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: February 20, 2024

	COGNITION THERAPEUTICS, INC.

	By:	/s/ Lisa Ricciardi
		Name: Lisa Ricciardi
		Title: President and Chief Executive Officer

EX-10.1 2 tm246515d1_ex10-1.htm EXHIBIT 10.1

Exhibit 10.1

COGNITION THERAPEUTICS, INC. 2021 EQUITY INCENTIVE PLAN

PERFORMANCE RESTRICTED STOCK UNIT

GRANT NOTICE AND AWARD AGREEMENT

Cognition Therapeutics, Inc., a Delaware corporation (the “Company”), pursuant to its 2021 Equity Incentive Plan (the “Plan”), hereby grants to the individual listed below (the “Participant”) the number of performance restricted stock units set forth below (the “Performance Restricted Stock Units” or “PRSUs”). The PRSUs described in this Grant Notice (the “Grant Notice”) are subject to the terms and conditions set forth in the Award Agreement attached hereto as Exhibit A (the “Agreement”) and the Plan, each of which is incorporated herein by reference. Unless otherwise defined herein, capitalized terms used in this Grant Notice and the Agreement will have the meanings defined in the Plan.

Name of Participant:

Grant Date:

No. of Performance Restricted Stock Units
for Milestone 1 Award (as defined below):

No. of Performance Restricted Stock Units
for Milestone 2 Award (as defined below):

Vesting Schedule:		See Appendix A attached to the Agreement

By signing below, Participant agrees to be bound by the terms and conditions of the Plan, the Agreement and this Grant Notice. This document may be executed, including by electronic means, in multiple counterparts, each of which will be deemed an original, and all of which together will be deemed a single instrument.

COGNITION THERAPEUTICS, INC.

PARTICIPANT



Name:			Name:

Title:

EXHIBIT A

TO PERFORMANCE RESTRICTED STOCK UNIT GRANT NOTICE

AWARD AGREEMENT

1.             Award of Performance Restricted Stock Units. Effective as of the Grant Date set forth in the Grant Notice, the Company has granted to Participant the number of PRSUs set forth in the Grant Notice, subject to the restrictions and on the terms and conditions set forth in the Grant Notice, the Plan and this Agreement. Each PRSU represents the right to receive one Share at the times and subject to the conditions set forth herein.

2.             Restrictions on Transfer of Award. This Award may not be sold, transferred, pledged, assigned or otherwise encumbered or disposed of by the Participant, and any shares of Stock issuable with respect to the Award may not be sold, transferred, pledged, assigned or otherwise encumbered or disposed of until (i) the PRSUs have vested as provided in Section 2 of this Agreement and (ii) shares of Stock have been issued to the Participant in accordance with the terms of the Plan and this Agreement.

3.             Earning of Performance Restricted Stock Units. Each Milestone Award (as such term is defined on on Appendix A, attached hereto, shall become earned based on the achievement of certain clinical milestones as described on Appendix A. The number of PRSUs determined to be earned shall be referred to herein as “Earned PRSUs.”

4.             Vesting of Performance Restricted Stock Units. With respect to any Earned PRSUs underlying the Milestone 1 Award and Milestone 2 Award, the restrictions and conditions of Section 1 of this Agreement shall lapse once the PRSUs become vested as set forth in Appendix A. The Administrator may at any time accelerate the vesting schedule specified in Appendix A or Paragraphs 3 and 4 of this Agreement. Upon Participant’s death during his or her continuous service with the Company, any PRSUs that are outstanding and unvested immediately prior to Participant’s death will remain outstanding for ninety (90) days, during which time the Committee may, in its sole discretion, vest all or a portion of such PRSUs. If the Committee decides to vest any PRSUs under this Section 4 it may condition such vesting on the execution by the Participant’s estate and/or beneficiaries of a general release of claims against the Company and its affiliates, in such form as the Company may prescribe (a “Release”). Upon the ninetieth (90th) day following Participant’s death, any portion of the unvested PRSUs that the Committee has not determined to vest in accordance with this Section 4 will be forfeited.

5.             Change in Control. Subject to the Participant’s continued service relationship with the Company through the consummation of any Change in Control (as defined in the Plan), all time-based vesting conditions of the earned PRSUs shall be deemed fully satisfied immediately prior to the consummation of the Change in Control.

6.             Termination of Service Relationship. If the Participant’s service relationship with the Company and its affiliated companies terminates for any reason (including death or disability) prior to the satisfaction of the earning or vesting conditions set forth in Sections 3 and 4 above, any PRSUs that have not become Earned PRSUs or have not otherwise vested as of such date shall automatically and without notice terminate and be forfeited, and neither the Participant nor any of his or her successors, heirs, assigns, or personal representatives will thereafter have any further rights or interests in such unvested Performance Restricted Stock Units.

7.             Settlement.

(a)            Shares will be issued in respect of Vested PRSUs within sixty (60) days following the applicable vesting date. For avoidance of doubt, this settlement timing is intended to comply with the “short-term deferral” exemption from Section 409A of the Code.

(b)            The PRSUs will not confer on Participant any rights as a stockholder of the Company until Shares are actually issued in settlement of such PRSUs.

(c)            Notwithstanding the foregoing, to the extent provided in Prop. Treas. Reg. § 1.409A-1(b)(4)(ii) or any successor provision, the Company may delay settlement of PRSUs if it reasonably determines that such settlement would violate federal securities laws or any other applicable law.

8.             Incorporation of Plan. Notwithstanding anything herein to the contrary, this Agreement shall be subject to and governed by all the terms and conditions of the Plan, including the powers of the Administrator set forth in Section 2 of the Plan. Capitalized terms in this Agreement shall have the meaning specified in the Plan, unless a different meaning is specified herein.

9.             Tax Withholding. The Participant shall, not later than the date or dates as of which the receipt or vesting of this Award becomes a taxable event for Federal income tax purposes, pay to the Company or make arrangements satisfactory to the Administrator for payment of any Federal, state, and local taxes required by law to be withheld on account of such taxable event. The Company shall have the authority to cause the required tax withholding obligation to be satisfied, in whole or in part, by withholding from shares of Stock to be issued to the Participant a number of shares of Stock with an aggregate Fair Market Value that would satisfy the withholding amount due.

10.           Section 409A of the Code. This Agreement shall be interpreted in such a manner that all provisions relating to the settlement of the Award are exempt from the requirements of Section 409A of the Code as “short-term deferrals” as described in Section 409A of the Code.

11.           Section 409A. The grant of PRSUs is intended to be exempt from Section 409A of the Code and should be interpreted accordingly. Nonetheless, the Company does not guarantee the tax treatment of the PRSUs.

12.           No Continuation of Service. Neither the Plan nor this Agreement will confer upon Participant any right to continue in the employment or service of the Company or any of its Affiliates, or limit in any respect the right of the Company or its Affiliates to discharge Participant at any time, for any reason.

13.           The Plan. Participant has received a copy of the Plan, has read the Plan and is familiar with its terms, and hereby accepts the Award subject to the terms and provisions of the Plan. Pursuant to the Plan, the Committee is authorized to interpret the Plan and to adopt rules and regulations not inconsistent with the Plan as it deems appropriate. Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Committee with respect to questions arising under the Plan, the Grant Notice or this Agreement.

14.           Company Policies. Participant agrees, in consideration for the grant of the Performance Restricted Stock Units, to be subject to any policies of the Company and its Affiliates regarding clawbacks, securities trading, and hedging or pledging of securities that may be in effect from time to time, or as may otherwise be required by applicable law, regulation or exchange listing standard.

15.           Entire Agreement. The Grant Notice and this Agreement, together with the Plan, represent the entire agreement between the parties with respect to the subject matter hereof and supersede any prior agreement, written or otherwise, relating to the subject matter hereof.

16.           Amendment. This Agreement may only be amended by a writing signed by each of the parties hereto; provided that the Company may amend this Agreement without Participant’s consent, if the amendment does not materially impair Participant’s rights hereunder.

17.           Governing Law. This Agreement will be construed in accordance with the laws of the State of Delaware, without regard to the application of the principles of conflicts of laws.

18.           Headings. The headings in this Agreement are for convenience only. They form no part of the Agreement and will not affect its interpretation.

19.           Tax Withholding. Participant acknowledges that the issuance of Shares hereunder will give rise to taxable income subject to required withholding. In accordance with Section 15 of the Plan, the obligations of the Company hereunder are conditioned on the Participant timely paying, or otherwise making arrangements satisfactory to the Company regarding the timely satisfaction of, such required withholding.

20.           Electronic Delivery of Documents. Participant authorizes the Company to deliver electronically any prospectuses or other documentation related to the Option and any other compensation or benefit plan or arrangement in effect from time to time (including, without limitation, reports, proxy statements or other documents that are required to be delivered to participants in such arrangements pursuant to federal or state laws, rules or regulations). For this purpose, electronic delivery will include, without limitation, delivery by means of e-mail or e-mail notification that such documentation is available on the Company’s Intranet site. Upon written request, the Company will provide to Participant a paper copy of any document also delivered to Participant electronically. The authorization described in this paragraph may be revoked by Participant at any time by written notice to the Company.

21.           Data Privacy Consent. In order to administer the Plan and this Agreement and to implement or structure future equity grants, the Company, its subsidiaries and affiliates and certain agents thereof (together, the “Relevant Companies”) may process any and all personal or professional data, including but not limited to Social Security or other identification number, home address and telephone number, date of birth and other information that is necessary or desirable for the administration of the Plan and/or this Agreement (the “Relevant Information”). By entering into this Agreement, the Participant (i) authorizes the Company to collect, process, register and transfer to the Relevant Companies all Relevant Information; (ii) waives any privacy rights the Participant may have with respect to the Relevant Information; (iii) authorizes the Relevant Companies to store and transmit such information in electronic form; and (iv) authorizes the transfer of the Relevant Information to any jurisdiction in which the Relevant Companies consider appropriate. The Participant shall have access to, and the right to change, the Relevant Information. Relevant Information will only be used in accordance with applicable law.

22.           Notices. Notices hereunder shall be mailed or delivered to the Company at its principal place of business and shall be mailed or delivered to the Participant at the address on file with the Company or, in either case, at such other address as one party may subsequently furnish to the other party in writing.

EX-101.SCH 3 cgtx-20240215.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 cgtx-20240215_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 5 cgtx-20240215_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 6 R1.htm IDEA: XBRL DOCUMENT

Cover	Feb. 15, 2024
Cover [Abstract]
Document Type	8-K
Amendment Flag	false
Document Period End Date	Feb. 15, 2024
Entity File Number	001-40886
Entity Registrant Name	Cognition Therapeutics, Inc.
Entity Central Index Key	0001455365
Entity Tax Identification Number	13-4365359
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	2500 Westchester Ave.
Entity Address, City or Town	Purchase
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10577
City Area Code	412
Local Phone Number	481-2210
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Title of 12(b) Security	Common Stock, par value $0.001 per share
Trading Symbol	CGTX
Security Exchange Name	NASDAQ
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	false

EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.0.1 html 1 23 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://cogrx.com/role/Cover Cover Cover 1 false false All Reports Book All Reports cgtx-20240215.xsd cgtx-20240215_lab.xml cgtx-20240215_pre.xml tm246515d1_8k.htm http://xbrl.sec.gov/dei/2023 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "tm246515d1_8k.htm": { "nsprefix": "cgtx", "nsuri": "http://cogrx.com/20240215", "dts": { "schema": { "local": [ "cgtx-20240215.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "cgtx-20240215_lab.xml" ] }, "presentationLink": { "local": [ "cgtx-20240215_pre.xml" ] }, "inline": { "local": [ "tm246515d1_8k.htm" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 59, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 23 }, "report": { "R1": { "role": "http://cogrx.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2024-02-15", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "tm246515d1_8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-02-15", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "tm246515d1_8k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://cogrx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://cogrx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://cogrx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://cogrx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://cogrx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://cogrx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://cogrx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://cogrx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://cogrx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://cogrx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://cogrx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://cogrx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://cogrx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://cogrx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://cogrx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://cogrx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://cogrx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://cogrx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://cogrx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://cogrx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://cogrx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://cogrx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://cogrx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://cogrx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://cogrx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://cogrx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://cogrx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://cogrx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://cogrx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://cogrx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://cogrx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://cogrx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://cogrx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://cogrx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://cogrx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://cogrx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://cogrx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://cogrx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://cogrx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://cogrx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://cogrx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://cogrx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://cogrx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://cogrx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://cogrx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://cogrx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://cogrx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://cogrx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://cogrx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://cogrx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://cogrx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://cogrx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://cogrx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://cogrx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://cogrx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://cogrx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://cogrx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://cogrx.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 15 0001104659-24-025580-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-24-025580-xbrl.zip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end XML 16 tm246515d1_8k_htm.xml IDEA: XBRL DOCUMENT 0001455365 2024-02-15 2024-02-15 iso4217:USD shares iso4217:USD shares false 0001455365 8-K 2024-02-15 Cognition Therapeutics, Inc. DE 001-40886 13-4365359 2500 Westchester Ave. Purchase NY 10577 412 481-2210 false false false false Common Stock, par value $0.001 per share CGTX NASDAQ true false